shared decision making

• 

Shared decision-making in kidney cancer

By Sharon Deveson Kell|2022-12-16T14:57:51+00:0016 Dec 2022|Drug treatments|

Over 400,000 people are diagnosed with kidney cancer globally each [...]

Read More

Comments Off on Shared decision-making in kidney cancer

• 

Shared decision-making in kidney cancer

By Sharon Deveson Kell|2022-07-08T08:07:34+00:008 Jul 2022|Uncategorized|

There was an interesting talk about shared decision-making for kidney [...]

Read More

Comments Off on Shared decision-making in kidney cancer

• 

ESMO 2019: IKCC global patient survey of kidney cancer patients in 43 countries

By Sharon Kell|2019-10-18T07:55:23+00:0018 Oct 2019|Cancer news|

Results from the International Kidney Cancer Coalition (IKCC) global patient [...]

Read More

Comments Off on ESMO 2019: IKCC global patient survey of kidney cancer patients in 43 countries

• 

Kidney cancer clinical trials: What you need to know

By Sharon Kell|2019-10-15T14:24:15+00:0015 Oct 2019|Cancer news|

In this article, Deb Maskens, founder of Kidney Cancer Canada [...]

Read More

Comments Off on Kidney cancer clinical trials: What you need to know

• 

Real world evidence as a complement to clinical trials

By Sharon Kell|2019-01-11T16:21:31+00:0011 Jan 2019|Uncategorized|

The review article highlights the usefulness of real world evidence [...]

Read More

Comments Off on Real world evidence as a complement to clinical trials

Patients do not feel involved in decisions about their own treatment: Results of the latest Adult Inpatient Survey by the Care Quality Commission

By Sharon Kell|2017-07-07T09:16:40+00:007 Jul 2017|Cancer news|

Results of the latest Adult Inpatient Survey by the Care [...]

Read More

Comments Off on Patients do not feel involved in decisions about their own treatment: Results of the latest Adult Inpatient Survey by the Care Quality Commission